<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_NU_Kazakhstan_Design skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:NU Kazakhstan/Design</SPAN></H1></DIV><DIV id="HQ_page"><DIV id="bodyContent"><DIV id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><P><TITLE>Valet — A free HTML5 Template by FREEHTML5.CO</TITLE></P><DIV class="container"><NAV id="fh5co-menu-wrap" role="navigation"><UL class="sf-menu" id="fh5co-primary-menu"><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan" class="active" style="color:rgb(255, 255, 255)">Home</A></LI><LI><A href="#" class="fh5co-sub-ddown" style="color:rgb(255, 255, 255)">Project</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/Parts">Parts</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/Results">Results</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/Design">Design</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/Model">Model</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/IoP">Improvement of Parts</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/FP">Future Plans</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/References">References</A></LI></UL><LI><A href="#" class="fh5co-sub-ddown" style="color:rgb(255, 255, 255)">Team</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/Team">Team</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/Collaborations">Collaborations</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/Attributions">Attributions</A></LI><LI><A href="#" class="fh5co-sub-ddown" style="color:rgb(255, 255, 255)">Notebook</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/Protocols">Protocols</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/Timeline">Calendar</A></LI><LI><A href="#" class="fh5co-sub-ddown" style="color:rgb(255, 255, 255)">Human Practices</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/HP/Silver">Public Engagement</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/HP/Gold_Integrated">Integrated HP</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/InterLab" style="color:rgb(255, 255, 255)">Interlab</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/Safety" style="color:rgb(255, 255, 255)">Safety</A></LI><LI><A href="https://2017.igem.org/Team:NU_Kazakhstan/Judging" style="color:rgb(255, 255, 255)">Judging Form</A></LI></NAV></DIV><DIV id="fh5co-main"><DIV class="container"><DIV class="row"><DIV class="col-md-8 col-md-push-4" id="fh5co-content"><DIV class="content-box animate-box" id="Introduction"><H2>Whole construct assembly design</H2><P>
Initially 4 transcriptional units were ordered from IDT company using iGEM promotion. These 4 units were designed (additional flanking 24 bp sequences) in a such way so that it could be amplified using PCR and appropriate primers (Figure 1).

</P><CENTER>Figure 1. Ordered sequences from IDT</CENTER><H3> List of designed primers </H3><P><LI>Fwd AphVIII (Primer 1) CTGGATTGGATGTGCTGTTGACCG </LI><LI>Rev AphVIII (Primer 2) GACAGTGGCTAATGGCTGAAACGC </LI><LI>Fwd ChrR (Primer 3) CTGGCAGGTACGATGTATCCTCGG </LI><LI>Rev ChrR (Primer 4) TGTAGGGAACTGGGTACGCAATCC </LI><LI>Fwd Chromodulin (Primer 5) CGTCAGGACACTTGTTGACTTGGC </LI><LI>Rev Chromodulin (Primer 6) TTGACCTGGTACGAAGTAGCCTGC </LI><LI>Fwd Supernova (Primer 7) AGATCCTAGTTTGACCTGCGTGCC </LI><LI>Rev Supernova (Primer 8) ATTGCTGGGAATCCTACGAGTCCG </LI></P><P>As it can be seen, these 4 transcriptional units have overlapping regions of the length of 49 bp each for Gibson Assembly (Figure 2). </P><CENTER>Figure 2. Gibson Assembly in silico (SnapGene)</CENTER><P>
Final construct looks like this (Figure 3):</P><CENTER>Figure 3. Final construct</CENTER></DIV><DIV class="content-box animate-box" id="rp"><H2>Design of primers for insertion into pChlamy_4 vector</H2><P>
pChlamy_4 vector ordered from company ThermoFisher was used to check presence of our proteins in C. reinhardtii by Western blotting. This vector is designed in a such way, so that after restriction-ligation cloning into multiple cloning sites, it is fused with resistance gene (Zeocin) and also has V5 epitope with 6xHis tag. During translation target protein is self-cleaved from resistance gene by FMDV 2A peptide.

In order to clone our coding sequence into the pChlamy_4 vector, transcriptional units were PCR amplified using specially primers that added EcoRI from 5’ end and XbaI+PstI from 3’ end. In addition to this, start codon and stop codon were removed, because coding sequence was fused to the resistance gene and addition of additional protein tags require absence of stop codon. After successful PCR, obtained amplicon could be digested with EcoRI+XbaI for further protein analysis (Western Blot/protein purification). In case if protein is desired to be expressed without any additional tags, EcoRI+PstI cloning can be used (Figure 4).
</P><CENTER>Figure 4. Scheme for insertion into pChlamy_4 vector</CENTER><P>Primers were carefully designed in such a way so that everything remained in frame (Figure 5):</P><CENTER>Figure 5. Careful design of primers for insertion into multiple cloning sites of pChlamy_4 vector (example on SuperNova coding sequence).
</CENTER></DIV><DIV class="content-box animate-box" id="fl"><H2>Design of primers for CPEC (Circular Polymerase Extension Cloning) cloning of our parts into pSB1C3 plasmid</H2><P>pSB1C3 linearized plasmid backbone was PCR amplified by using these two following primers:</P>Rwd pSB1C3, 39bp
<LI>tactagtagcggccgctgcagtccggcaaaaaagggcaa</LI>
Rev pSB1C3, 41bp
<LI>tctagaagcggccgcgaattccagaaatcatccttagcgaa</LI><P>Each part was also PCR amplified in such a way so that it had flanking BioBrick Prefix and Suffix (Figure 6).

Following primers were used for each part (3 bp from 5’ end corresponding to pSB1C3 backbone, BioBrick prefix/suffix and 16-20 bp of overlapping nucleotides with target region at 3’ end of each primer):</P>
Fwd ChrR, 43bp
<LI>ctggaattcgcggccgcttctagatgagcgagaagctgcaggt</LI>
Rev ChrR, 43bp
<LI>gactgcagcggccgctactagtattagatcttcacgcgctgaa</LI>
Fwd SuperNova, 43bp
<LI>ctggaattcgcggccgcttctagatgggtagcgaggtcggtcc</LI>
Rev SuperNova, 42bp
<LI>gactgcagcggccgctactagtattatcctcatcggacccga</LI>
Fwd promoter, 44bp
<LI>ctggaattcgcggccgcttctagagacggcggggagctcgctga</LI>
Rev promoter, 42bp
<LI>gactgcagcggccgctactagtctgcaaatggaaacggcgac</LI>

Fwd Chromodulin, 39bp
<LI>ctggaattcgcggccgcttctagatggaggaggaggagg</LI>
Rev Chromodulin, 39bp
<LI>gactgcagcggccgctactagtttaatcatcgccctcct</LI>
Fwd terminator, 44bp
<LI>ctggaattcgcggccgcttctagagctccgtgtaaatggaggcg</LI>
Rev terminator, 42bp
<LI>gactgcagcggccgctactagtgcttcaaatacgcccagccc</LI><CENTER>Figure 6. Circular Polymerase Extension Cloning scheme
</CENTER><P>After PCR purification of two amplicons (part and backbone), CPEC reaction was run. Then CPEC product was transformed into E. coli and plasmid extraction was performed.</P></DIV></DIV><DIV class="col-md-4 col-md-pull-8 left-sidebar" id="fh5co-sidebar"><DIV class="sidebar-box animate-box"><H3 class="sidebar-heading">Design</H3><UL class="sidebar-links"><LI><A id="intr_sb" href="#">Whole construct assembly design</A></LI><LI><A id="rp_sb" href="#">Design of primers for insertion into pChlamy_4 vector</A></LI><LI><A id="fl_sb" href="#">Design of primers for CPEC (Circular Polymerase Extension Cloning) cloning of our parts into pSB1C3 plasmid</A></LI></UL></DIV></DIV></DIV></DIV></DIV><FOOTER role="contentinfo" id="fh5co-footer"><DIV class="container"><DIV class="row"><DIV class="col-md-4 col-sm-6 footer-box"><H3 class="fh5co-footer-heading">School of Science and Technology</H3><UL class="fh5co-footer-links"><LI>Nazarbayev University</LI><LI>Astana, Kazakhstan</LI></UL></DIV><DIV class="col-md-4 col-sm-12 footer-box"><H3 class="fh5co-footer-heading">Get in touch</H3></DIV></DIV></DIV></FOOTER></DIV></DIV></DIV></DIV></DIV></BODY></HTML>